Home » today » Business » Siemens subsidiary invests in cancer control | Nachrichten.at

Siemens subsidiary invests in cancer control | Nachrichten.at

The German medical technology group Siemens Healthineers wants to significantly expand its cancer research and therapy business through a multi-billion euro acquisition. For this purpose, the US company Varian is to be bought for $ 16.4 billion (14 billion euros), as the listed Siemens subsidiary announced on Sunday. This is the largest takeover so far in the company’s history.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.